Why ASX healthcare shares are a no-brainer for the 2020s

Here's why I think ASX healthcare shares like CSL Limited (ASX: CSL) are a no-brainer for 2020 investments.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

I would describe ASX healthcare shares as a somewhat 'under-the-radar' sector of the share market. Sure, market-darling CSL Limited (ASX: CSL) has managed to sneak up to be one of the most popular ASX shares to hold in a modern portfolio.

But out of the ASX 50 (that's the largest 50 Aussie public companies) – only 4 are classified as belonging to the healthcare industry.

They are CSL, Ramsay Health Care Limited (ASX: RHC), Sonic Healthcare Limited (ASX: SHL) and Cochlear Limited (ASX: COH).

If you were splitting hairs, you could also throw in Medibank Private Ltd (ASX: MPL), although it's technically a Financial.

But I think healthcare is one of the best places to be investing as we begin the new decade. In my view, the under-representation of healthcare in the ASX 50 just means there's plenty of room for growth!

Why?

Well, I have 2 rock-solid (in my opinion, anyway) reasons.

1. Ageing demographics

It's no secret that our population is ageing. According to reporting in the Sydney Morning Herald, it's estimated that by the year 2056, there is expected to be just 2 workers for every 1 retiree – down from today's ratio of 4-to-1.

That's a scary statistic, but it's also one that I think indicates a lot of potential in the healthcare sector for investing today.

2. Government support

As our population ages, there is going to inevitably be more pressure on government services to provide the same level of care from fewer taxes being proportionally paid by less workers. As a result, I expect governments to increasingly rely on the private sector to fill this gap.

This might come through the use of higher tax incentives like the private health insurance rebate and Medicare levy, or grants to private health providers to shoulder some of this burden.

Whichever way the cookie crumbles, I think this sector will stand to benefit as we stare down this barrel.

Yes, I think the government will be buying more vaccines from CSL as time goes on.

Yes, I think Ramsay Health Care (and its extensive network of private hospitals) will benefit in more than one way from government policy in the future.

And yes, I think Medibank and other private insurers will continue to be encouraged by the state to take some of the pressure off Medicare.

Foolish takeaway

All in all, healthcare is a sector that I believe is a no-brainer to be investing in this decade and beyond, for the reasons outlined above. By looking at the demographic trends that are hitting our population, it's really not too hard to imagine the benefits that are going to flow into the healthcare sector as a whole. It's a pie I certainly want a slice of!

Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd. and CSL Ltd. The Motley Fool Australia has recommended Cochlear Ltd., Ramsay Health Care Limited, and Sonic Healthcare Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A senior pharmacist talks to a customer at the counter in a shop
Healthcare Shares

Is it too late to buy Sigma shares to cash in on the Chemist Warehouse deal?

Can investors still make healthy returns with this stock?

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

Why the Mesoblast share price is diving 18% after an FDA win

Investors are sending the Mesoblast share price tumbling on Friday. But why?

Read more »

A happy doctor in a white coat dancing due to his excitement over the EBOS acquisition
Healthcare Shares

Mesoblast share price rockets 30% on big US FDA news

Big news is giving this biotech a huge lift on Thursday.

Read more »

Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
Healthcare Shares

Guess which ASX healthcare stock is jumping 12% on Wednesday

This shares is rocketing this morning. But why? Let's find out.

Read more »

Man holding out Australian dollar notes, symbolising dividends.
Healthcare Shares

Here is the dividend forecast to 2029 for CSL shares

Can this blue-chip giant provide healthy dividend income?

Read more »

a doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.
Healthcare Shares

The best ASX 200 healthcare stocks to buy in 2025

These shares could give your portfolio a healthy boost next year according to Bell Potter.

Read more »

In the lab at work, the mature adult woman and young adult man smile as they review the results of their successful experimentation.
Healthcare Shares

ASX 300 healthcare stock lifts off on promising new results

Up 28% in a year, the ASX healthcare stock is leaping higher on Thursday.

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

If you'd invested $5,000 in this ASX 300 healthcare stock a year ago, you'd now have $30,000!

This stock has made millions for investors over just a few months.

Read more »